File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Neoadjuvant brachytherapy and chemotherapy followed by radical surgery for stage IB2 and IIA cervical cancer: A retrospective comparison with chemoirradiation

TitleNeoadjuvant brachytherapy and chemotherapy followed by radical surgery for stage IB2 and IIA cervical cancer: A retrospective comparison with chemoirradiation
Authors
Keywordscervical cancer
radical hysterectomy
radiotherapy
survival
complications
Issue Date2018
PublisherSpandidos Publications. The Journal's web site is located at http://www.spandidos-publications.com/mco
Citation
Molecular and Clinical Oncology, 2018, v. 8 n. 4, p. 617-622 How to Cite?
AbstractThe aim of the present study was to assess the immediate and long-term results of preoperative brachytherapy and chemotherapy followed by radical surgery compared with those of standard chemoirradiation in patients with stage IB2-IIA cervical cancer. The medical records of 70 patients with stage IB2 and IIA cervical cancer who were treated between June 2006 and June 2010 were reviewed. The patients received either standard chemoirradiation (CRT) treatment (n=20) or neoadjuvant brachytherapy with one cycle of chemotherapy followed by radical hysterectomy [operation (OT) group; n=50]. Further adjuvant chemoirradiation was administered to patients with high-risk disease. Early and late complications as well as survival were compared between the two groups. No serious operative complications occurred in the OT group. In the CRT group, the incidence of symptomatic vaginal stenosis, as well as that of proctitis and cystitis, was higher compared with that in the OT group (35 vs. 4% and 20 vs. 2%, repectively). The median follow-up period was 52 months (range, 11-84 months). In the CRT group, the 3‑year overall and disease-free survival rates were 95% [95% confidence interval (CI): 76.14‑86.46] and 90% (95% CI: 59.94‑73.66), respectively, whereas in the OT group, the respective rates were 90% (95% CI: 72.93‑83.07) and 90% (95% CI: 71.84‑82.96). In conclusion, the survival of patients with stage IB2‑IIA cervical cancer treated with preoperative brachytherapy and chemotherapy followed by radical surgery was similar to that of patients treated with chemoirradiation, but with a more favorable side effect profile. Thus, this tri‑modal treatment option requires further evaluation in prospective randomized studies.
Persistent Identifierhttp://hdl.handle.net/10722/281709
ISSN
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorMa, Y-
dc.contributor.authorZhao, G-
dc.contributor.authorQi, J-
dc.contributor.authorSun, P-
dc.contributor.authorLiu, C-
dc.contributor.authorQu, P-
dc.contributor.authorChan, KKL-
dc.date.accessioned2020-03-22T04:18:35Z-
dc.date.available2020-03-22T04:18:35Z-
dc.date.issued2018-
dc.identifier.citationMolecular and Clinical Oncology, 2018, v. 8 n. 4, p. 617-622-
dc.identifier.issn2049-9450-
dc.identifier.urihttp://hdl.handle.net/10722/281709-
dc.description.abstractThe aim of the present study was to assess the immediate and long-term results of preoperative brachytherapy and chemotherapy followed by radical surgery compared with those of standard chemoirradiation in patients with stage IB2-IIA cervical cancer. The medical records of 70 patients with stage IB2 and IIA cervical cancer who were treated between June 2006 and June 2010 were reviewed. The patients received either standard chemoirradiation (CRT) treatment (n=20) or neoadjuvant brachytherapy with one cycle of chemotherapy followed by radical hysterectomy [operation (OT) group; n=50]. Further adjuvant chemoirradiation was administered to patients with high-risk disease. Early and late complications as well as survival were compared between the two groups. No serious operative complications occurred in the OT group. In the CRT group, the incidence of symptomatic vaginal stenosis, as well as that of proctitis and cystitis, was higher compared with that in the OT group (35 vs. 4% and 20 vs. 2%, repectively). The median follow-up period was 52 months (range, 11-84 months). In the CRT group, the 3‑year overall and disease-free survival rates were 95% [95% confidence interval (CI): 76.14‑86.46] and 90% (95% CI: 59.94‑73.66), respectively, whereas in the OT group, the respective rates were 90% (95% CI: 72.93‑83.07) and 90% (95% CI: 71.84‑82.96). In conclusion, the survival of patients with stage IB2‑IIA cervical cancer treated with preoperative brachytherapy and chemotherapy followed by radical surgery was similar to that of patients treated with chemoirradiation, but with a more favorable side effect profile. Thus, this tri‑modal treatment option requires further evaluation in prospective randomized studies.-
dc.languageeng-
dc.publisherSpandidos Publications. The Journal's web site is located at http://www.spandidos-publications.com/mco-
dc.relation.ispartofMolecular and Clinical Oncology-
dc.subjectcervical cancer-
dc.subjectradical hysterectomy-
dc.subjectradiotherapy-
dc.subjectsurvival-
dc.subjectcomplications-
dc.titleNeoadjuvant brachytherapy and chemotherapy followed by radical surgery for stage IB2 and IIA cervical cancer: A retrospective comparison with chemoirradiation-
dc.typeArticle-
dc.identifier.emailChan, KKL: kklchan@hkucc.hku.hk-
dc.identifier.authorityChan, KKL=rp00499-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.3892/mco.2018.1580-
dc.identifier.hkuros309438-
dc.identifier.volume8-
dc.identifier.issue4-
dc.identifier.spage617-
dc.identifier.epage622-
dc.identifier.isiWOS:000456301700022-
dc.publisher.placeGreece-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats